SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Apr 2015 07:00

RNS Number : 6595J
Victrex PLC
09 April 2015
 



 

 

 

 

 

9 April 2015

Victrex plc

Half year and pre-close trading update

'A good first half; well positioned for full year progress'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its half year and pre-close trading update for the six months ended 31 March 2015.

Overall, Victrex delivered a good first half performance. Group revenue of £130.3m was 9% ahead of the prior year (H1 2014: £119.9m), with Group sales volume of 2,028 tonnes 28% ahead of the prior year (H1 2014: 1,584 tonnes). The first half performance reflects a continuing positive contribution from Consumer Electronics and slightly lower sales in our Invibio medical business. Group gross margins saw improvement compared to the first half of 2014, reflecting better manufacturing efficiencies.

In Victrex Polymer Solutions (VPS), lower sales into oil and gas were offset by growth in our other markets. Commissioning of the first production stream on our third PEEK manufacturing plant is now complete and successfully started up on schedule. In Invibio, performance reflected the impact from industry consolidation in the US during Q1, as previously communicated, although we saw an improvement in Q2. Invibio revenue of £25.9m was 4% down on the prior year (H1 2014: £26.9m) and flat in constant currency, although our focus remains on continued improvement as we enter the second half.

The adverse currency impact seen by the Group during the first half will also continue into the second half. However, as previously communicated, we continue to expect that we will fully overcome the currency impact for the full year.

David Hummel, Chief Executive of Victrex, said: "Victrex delivered a good first half performance overall. Although we are mindful of the tougher comparatives for the second half and the continued caution in the oil and gas market, we remain well positioned for progress over the full year."

Victrex will report its interim results on Tuesday 19 May 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPCUPAGAR
Date   Source Headline
16th Dec 20154:37 pmRNSDirector/PDMR Shareholding
15th Dec 201512:03 pmRNSDirector/PDMR Shareholding
9th Dec 20152:34 pmRNSDirector/PDMR Shareholding
8th Dec 20154:43 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSFinal Results
4th Dec 20154:07 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSHolding(s) in Company
1st Dec 20152:54 pmRNSBlocklisting Interim Review
30th Nov 20153:39 pmRNSTotal Voting Rights
20th Nov 20154:04 pmRNSHolding(s) in Company
17th Nov 20154:08 pmRNSDirector/PDMR Shareholding
30th Oct 201510:32 amRNSTotal Voting Rights
19th Oct 20153:13 pmRNSDirector/PDMR Shareholding
8th Oct 20157:00 amRNSTrading Statement
30th Sep 20151:56 pmRNSTotal Voting Rights
29th Sep 20154:19 pmRNSDirectorate Change
28th Sep 20154:28 pmRNSDirector/PDMR Shareholding
24th Sep 201511:50 amRNSDirector/PDMR Shareholding
21st Sep 201511:42 amRNSHolding(s) in Company
17th Sep 201511:23 amRNSDirector/PDMR Shareholding
28th Aug 201512:06 pmRNSTotal Voting Rights
26th Aug 20154:24 pmRNSHolding(s) in Company
18th Aug 20152:12 pmRNSDirector/PDMR Shareholding
31st Jul 20154:09 pmRNSTotal Voting Rights
31st Jul 20152:24 pmRNSHolding(s) in Company
31st Jul 201512:08 pmRNSDirectorate Change
21st Jul 20157:00 amRNSInterim Management Statement
20th Jul 20159:58 amRNSDirector/PDMR Shareholding
30th Jun 20153:38 pmRNSTotal Voting Rights
26th Jun 201511:07 amRNSDirector Declaration
17th Jun 20154:06 pmRNSDirector/PDMR Shareholding
1st Jun 20153:52 pmRNSBlocklisting Interim Review
29th May 201510:00 amRNSTotal Voting Rights
26th May 20154:39 pmRNSDirector/PDMR Shareholding
19th May 20153:58 pmRNSDirector/PDMR Shareholding
19th May 20159:52 amRNSVictrex first half pretax profit jumps 10%
19th May 20157:00 amRNSHalf Yearly Report
11th May 20154:31 pmRNSHolding(s) in Company
6th May 20154:34 pmRNSHolding(s) in Company
30th Apr 20152:30 pmRNSTotal Voting Rights
28th Apr 20154:34 pmRNSHolding(s) in Company
21st Apr 20157:00 amRNSCapital Markets Day
20th Apr 20153:23 pmRNSDirector/PDMR Shareholding
9th Apr 20157:00 amRNSTrading Statement
31st Mar 20153:25 pmRNSTotal Voting Rights
26th Mar 20153:20 pmRNSDirectorate Change
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 20154:32 pmRNSHolding(s) in Company
17th Mar 20152:28 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.